
Girish Malhotra
Girish Malhotra is a CPhI Worldwide Annual Industry Report member, and the President of EPCOT International, USA.
Girish Malhotra is a CPhI Worldwide Annual Industry Report member, and the President of EPCOT International, USA.
June 21, 2017
Faster review and approval processes could lower drug costs. Can we axe approval times for abbreviated new drug applications down to three months?
1 min read
Receive the latest analytical science news, personalities, education, and career development – weekly to your inbox.
False
False